• Research Professor
  • Phone: 401.277.5001
  • Email:
  • Office Location: Avedisian Hall, 7 Greenhouse Road, Kingston, RI 02881


Lynn E. Taylor, MD, FACP, FAASLD, FIDSA, is an internal medicine, primary care, HIV and viral hepatitis physician, clinical researcher, educator and public health advocate focused on whole-person medical care of people who use drugs, prevention and care of hepatitis C virus infection (HCV) in vulnerable populations, and improving the health of drug-involved populations. For 25 years she has worked enhancing prevention and treatment of infectious consequences of opioid use disorder (OUD) including HIV/AIDS, viral hepatitis, and sexually transmitted infections (STIs) and engaging in related research and policy work to improve individual and public health. She has worked on numerous NIH, ACTG, CSAT/SAMHSA, PCORI and private foundation-funded studies.

For four and a half years Dr. Taylor served as a Member of the U.S. Centers for Disease Control and Prevention and Health Resources and Services Administration Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment. For the World Health Organization, Dr. Taylor served as advisor on people who inject drugs (PWID) and people living with HIV/AIDS for the Standard Guidelines for Screening, Care and Treatment of Chronic HCV. For the International Network on Health and Hepatitis in Substance Users she served as member of the International Consensus Guidelines Committee Management of HCV in PWID. She has been honored for her work at The White House.

Dr. Taylor was Rhode Island site Principal Investigator for the Patient-Centered Outcomes Research Institute 6-year research award, “Clinical Management of HCV Infection: Patient-Centered Models of HCV Care for People Who Inject Drugs (PWID).” She developed and directs Rhode Island Defeats Hep C (RID Hep C),, a comprehensive program to Identify, Treat, Cure, Prevent and Eliminate HCV in Rhode Island. Part of this effort includes developing and directing co-located HCV care at opioid use disorder treatment, HIV health and primary care programs, where people can most readily access medical care.

Dr. Taylor is Co-Founder and Co-Director of, MomDocFamily ( The mission of MomDocFamily is to provide mentorship and support for women physicians facing the challenges and rewards of combining a medical career with motherhood.


HIV, HCV, hepatitis B virus, infectious consequences of substance use, integrated care, health disparities, people who inject drugs, opioid use disorder


B.A. Harvard-Radcliffe College, 1988
M.D. University of Pittsburgh School of Medicine, 1997
National Health Service Corps Scholarship, U.S. Department of Health and Human Services, Public Health Service, Bureau of Primary Care, 1994 – 1996
Internal Medicine Residency, Brown University School of Medicine, Rhode Island Hospital, Providence, RI, 1997 – 2000
NIH/NIDA T32 Research Fellowship “HIV and Other Infectious Consequences of Substance Abuse.”, Brown University School of Medicine, The Miriam Hospital, Providence, RI, 2003 – 2005

Selected Publications

Original Publications in Peer-Reviewed Journals

Rich JD, Macalino GE, McKenzie M, Taylor LE, Burris S. Syringe prescription to prevent HIV infection in Rhode Island: a case study. Am J Public Health. 2001 May;91(5):699-700. PMID: 11344871

Taylor LE, Costello T, Alt E, Yates G, Tashima K. Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals. 2002 Aug16;16(12):1700-1. PMID: 12172100

Rich JD, Martin EG, Macalino GE, Paul RV, McNamara S, Taylor LE. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S58-61. PMID: 12489617

Taylor LE, Runarsdottir V, Zampi A, Osei A, Sanford S, Macalino G, McKenzie M, Burris S, Gross M, Reinert S, Rich JD. Would you consider prescribing syringes to injection drug users? Addiction Medicine Conference Survey. J Addict Dis. 2003;22(1):67-78. PMID: 12661980

Allen SA, Spaulding AC, Osei AM, Taylor LE, Cabral AM, Rich JD. Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med. 2003 Feb 4;138(3):187-90. PMID: 12558357

Rich JD, Taylor L, Mehrotra M, Mason R, Stozek M, Stancliff S. Prescribing syringes to injection drug users: what the family physician should know. Am Fam Physician. 2003 Jul 1;68(1):45-7. PMID: 12887113

Rich JD, McKenzie M, Macalino GE, Taylor LE, Sanford-Colby S, Wolf F, McNamara S, Mehrotra M, Stein MD. A syringe prescription program to prevent infectious disease and improve health of injection drug users. J Urban Health. 2004 Mar;81(1):122-34. PMID: 15047791

Stozek MA, Taylor LE, LeBreux L, Olson J, Wolf F, Rich JD. Prescribing syringes to injection drug users with HIV: an important clinical and public health tool. J Assoc Nurses AIDS Care. 2004 Mar-Apr;15(2):59-63. PMID: 15090134

Macalino GE, Hou JC, Kumar MS, Taylor LE, Sumantera IG, Rich JD. Hepatitis C infection and incarcerated populations. Int’l J Drug Pol. 2004 Apr;15(2):103-14.

Taylor LE. Delivering care to injection drug users coinfected with HIV and hepatitis C virus. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S355-61. PMID: 15768348

Flanigan TP, Taylor LE, Mitty JA. Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection.  Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S346-8. PMID: 15768346

Taylor LE, Gholam PM, Schwartzapfel B, Rich JD. Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report. AIDS Read. 2005 Nov; 5(11):629-31,634-6,638. PMID: 16323305

Blackard JT, Komurian-Pradel F, Perret M, Sodoyer M, Smeaton L, St. Clair JB, Chapman S, Taylor LE, Paranhos-Baccalà G, Chung RT. Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection.  J Med Virol. 2006 Feb;78(2):202-07. PMID: 16372286

McGovern BH, Ditelberg JS, Taylor LE, Gandhi RT, Christopoulos KA, Chapman S, Schwartzapfel B, Rindler E, Fiorino AM, Zaman MT, Sax PE, Graeme-Cook F, Hibberd PL. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis. 2006 Aug 1;43(3):365-72. PMID: 16804853

Lai AR, Tashima KT, Taylor LE. Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus. AIDS Patient Care STDS. 2006 Oct;20(10):678-92. PMID: 17052138

Brim N, Zaller N, Taylor LE, Feller E. Twinrix vaccination schedules among injecting drug users. Expert Opin Bio. Ther. 2007 Mar;7(3):379-89. PMID: 17309329

Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ; North American Liver Cancer in HIV Study Group. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients; a U.S.-Canadian multicenter study.  J Hepatol. 2007 Oct;47(4):527-37. PMID: 17692986

Chew KW, Allen SA, Taylor LE, Rich JD, Feller E. Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C. J Clin Gastroenterol. 2009 Aug;43(7):686-91. doi: 10.1097/MCG.0b013e31818dd94c. Erratum in: J Clin Gastroenterol. 2009 Nov-Dec;43(10):1010. PMID: 19295448

Taylor LE, Mayer Acute hepatitis C virus infection in an HIV clinic and in community settings. Gastroenterology 2009 Jun;136(7):2411-2. doi: 10.1053/j.gastro.2009.04.043. PMID: 19409986

Taylor LE. HIV/viral hepatitis coinfection: the Immunology Center experience. Med Health R.I. 2009 Jul;92(7):234-6. PMID: 19685638

Dryer PD, Limketkai BN, Martin CM, Ma G, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ, Blackard JT. Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naïve women. Journal of Antimicrobial Chemotherapy 2009 Nov;64(5):945-8. doi: 10.1093/jac/dkp328. PMID: 19767319

Tate DF, Conley J, Paul RH, Coop K, Zhang S, Zhou W, Laidlaw DH, Taylor LE, Flanigan T, Navia B, Cohen R, Tashima K. Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients. Brain Imaging Behav. 2010 Mar;4(1):68-79. doi: 10.1007/s11682-009-9086-z. PMID: 20503115

Rich JD, Taylor LE. The beginning of a new era in understanding hepatitis C virus prevention. J Infect Dis. 2010 Oct 1;202(7):981-3. doi: 10.1086/656213. PMID:

Blackard JT, Ma G, Limketkai BN, Welge JA, Dryer PD, Martin CM, Hiasa Y, Taylor LE, Mayer KH, Jamieson DJ, Sherman KE. Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. J Clin Microbiol. 2010 Nov;48(11):4256-9. doi: 10.1128/JCM.01613-10. PMID: 20810773

Blackard JT, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Jamieson DJ, Gardner L, Sherman KE. HIV mono-infection is associated with FIB-4 – A noninvasive index of liver fibrosis – in women. Clin Infect Dis. 2011 Mar 1;52(5):674-80. doi: 10.1093/cid/ciq199. PMID: 21248367.

Taylor LE, Holubar M, Wu K, Bosch RJ, Wyles DL, Davis JA, Mayer KH, Sherman KE, Tashima KT. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis. 2011 Mar 15;52(6):812-8. doi: 10.1093/cid/ciq201. PMID: 21282184

Taylor LE, Gaitanis MM, Beckwith CG. Commentary: A Call for Routine HIV Testing Among Patients with Hepatitis C Virus Infection. The Open Infectious Diseases Journal. 2011 June 29;5:19-20. doi: 10.2174/1874279301105010019

Taylor LE, Bowman SE, Chapman S, Zaller N, Stein MD, Cioe P, Maynard M, McGovern BH. Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy. Drug Alcohol Depend. 2011 Jul 1;116(1-3):233-7. doi: 10.1016/j.drugalcdep.2010.11.016. PMID: 21177046

Taylor LE, DeLong AK, Maynard MA, Chapman S, Gholam P, Blackard JT, Rich J, Mayer KH. Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk. AIDS Patient Care STDs. 2011 Oct;25(10):571-7. doi: 10.1089/apc. 2011.0106. Epub 2011 Aug 22. PMID: 21859307

Rich JD, Wohl DA, Beckwith CG, Spaulding AC, Lepp NE, Baillargeon J, Gardner A, Avery A, Altice FL, Springer S; Centers for AIDS Research—Collaboration on HIV in Corrections (CFAR-CHIC) Working Group. Taylor LE, Collaborator. HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep. 2011 Dec;8(4):288-96. doi: 10.1007/s11904-011-0095-3. PMID: 21904902

MacNamara MM, Moren K, Taylor LE, Taylor JS. State-wide support for physician-mothers who are breastfeeding. Med Health RI.  2012 Jan;95(1):9-13. PMID: 22439455

Mayer KH, Bush T, Henry K, Overton ET, Hammer J, Richardson J, Wood K, Conley L, Papp J, Caliendo AM, Patel P, Brooks JT; SUN Investigators. Taylor LE, Collaborator. Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions. Sex Transm Dis. 2012 Jan;39(1):1-7. doi: 10.1097/OLQ.0b013e31823b1922. PMID: 22183836

Blackard JT, Ma G, Welge JA, Martin C, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. J Med Virol. 2012 Feb;84(2):242-52. doi: 10.1002/jmv.22269. PMID: 22170544

MacNamara MM, Taylor JS, Grimm KJ, Taylor LE, Gottlieb, AS. Using a professional organization, MomDocFamily, to understand the lives of physician-mothers. Med Health RI.  2012 Jun;95(6):189-93. PMID: 22866508

Taylor LE, Swan T, Mayer KH. HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis. 2012 Jul;55 Suppl 1:S33-42. doi: 10.1093/cid/cis367. PMID: 22715212

Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL. Buprenorphine for Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Patients: Does It Serve as a Bridge to Hepatitis C Virus Therapy? J Addict Med. 2012 Sep;6(3):179-85. doi: 10.1097/ADM.0b013e318257377f. PMID: 22614935

Westbrook ML, Garg S, Chapman S, Cu-Uvin S, Tashima KT, Taylor LE. Hepatocellular Carcinoma in HIV-Infected Women: Two Case Reports.  R I Med J (2013). 2013 Jan 4;96(1):21-4. PMID: 23638454

Garg S, Taylor LE, Grasso C, Mayer KH. Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a Boston community health center. Clin Infect Dis. 2013 May;56(10):1480-7. doi: 10.1093/cid/cit054. Erratum in: Clin Infect Dis. 2013 Sep;57(5):779. PMID: 23386630.

Taylor LE, Swan T, Matthews GV. Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy. Clin Infect Dis. 2013 Aug;57 Suppl 2:S118-24. doi: 10.1093/cid/cit326 PMID: 23884059

Robaeys G, Grebely J, Mauss S, Bruggmann P, Moussalli J, De Gottardi A, Swan T, Arain A, Kautz A, Stover H, Wedemeyer H, Schaefer M, Taylor LE, Backmund M, Dalgard O, Prins M, Dore GJ, and on behalf of the International Network on Hepatitis in Substance Users. Recommendations for the management of hepatitis C virus infection among people who inject drugs. Clin Infect Dis. 2013 Aug; 57 Suppl 2:S129-37 doi: 10.1093/cid/cit302. PMID: 23884061

Taylor LE, Foont JA, DeLong AK, Wurcel A, Linas BP, Chapman S, Maynard MA, Cu-Uvin S, Mayer KH. The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic. AIDS Patient Care STDS. 2014 Jan;28(1):4-9. doi: 10.1089/apc.2013.0130. PMID: 24428794.

Merchant RC, Baird JR, Liu T, Taylor LE, Montague BE, Nirenberg TD. Brief intervention to increase emergency department uptake of combined rapid human immunodeficiency virus and hepatitis C screening among a drug misusing population. Acad Emerg Med. 2014 Jul;21(7):752-67. doi: 10.1111/acem.12419. PMID: PMCID: PMC4135533.

Kinnard EN, Taylor LE, Galárraga O, Marshall BD. Estimating the true prevalence of hepatitis C in Rhode Island. R I Med J. 2014 Jul 1;97(7):19-24. PMID: 24983016. PMCID:

Taylor LE. Hepatitis C virus infection:  from margin to center in Rhode Island and beyond. R I Med J. 2014 Jul 1;97(7):15-8. PMID: 24983015.

Merchant RC, Baird JR, Liu T, Taylor LE. HCV among The Miriam Hospital and Rhode Island Hospital Adult ED Patients. R I Med J. 2014 Jul 1;97(7):35-9. doi:10.1111/acem. 12419. PMID: 24983020. PMCID: PMC4349365

Taylor LE. What price for a cure? R I Med J. 2014 Jul 1;97(7):16-7. PMID: 25184174.

Freiman JM, Huang W, White LF, Geng EH, Hurt CB, Taylor LE, Overton ET, Cachay ER, Kitahata MM, Moore RD, Rodriguez B, Mayer KH, Linas BP. Current practices of screening for incident hepatitis C Virus (HCV) infection among HIV-infected, HCV-Uninfected individuals in primary care. Clin Infect Dis. 2014 Dec 15;59(12):1686-93. doi: 10.1093/cid/ciu698.PMID: 25186591. PMCID: PMC4311177

Sangal RB, Taylor LE, Gillani F, Poppas A, Klinger JR, Ventetuolo CE. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection. Ann Am Thorac Soc. 2014 Dec;11(10):1553-9. doi: 10.1513/AnnalsATS.201405-225OC. PMID: 25375659. PMCID: PMC4298977

Blackard JT, Ma G, Welge JA, King C, Taylor LE, Mayer KH, Klein RS, Celentano DD, Sobel J, Jamieson DJ, Gardner L. GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV infection. PLoS ONE. 2014 Dec. 10;9(12):e114467. doi: 10.1371/journal.pone.0114467. PMID: 25493916

Kofman A, Litwin AH, Swan T, Pinkston M, Rizzo B, Bryant V, Taylor LE. Short Communication: Heterogeneity in Drug and Alcohol Use-Related Exclusion Criteria in Direct Acting Antiviral Agent Hepatitis C Treatment Trials for Individuals Coinfected with Hepatitis C Virus and HIV.  Clin Res HIV/AIDS 2015 2(2): 1019.

Barua S, Greenwald R, Grebely J, Dore GJ, Swan T, Taylor LE. Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States. Ann Intern Med. 2015 Aug 4;163(3):215-23. doi: 10.7326/M15-0406. PMID: 26120969

Grebely J, Haire B, Taylor LE, Macneill P, Litwin AH, Swan T, Byrne J, Levin J, Bruggmann P, Dore GJ; International Network for Hepatitis in Substance Users. Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data? J Hepatol. 2015 Oct;63(4):779-82. doi: 10.1016/j.jhep.2015.06.014. PMID: 26254264. PMC – In Process

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M,  Taylor LE, Dore GJ; International Network for Hepatitis in Substance Users. Recommendations for the management of hepatitis C virus infection among people who inject drugs. Int J Drug Policy. 2015 Oct;26(10):1028-38. doi: 10.1016/j.drugpo. 2015.07.005. PMID: 26282715

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; im Namen vom International Network on Hepatitis care in Substance Users. Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden. Int J Drug Policy. 2015 Nov 28. pii: S0955-3959(15)00352-7. doi: 10.1016/j.drugpo.2015.11.010. [Epub ahead of print] German. PMID: 26749563

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; l’International Network on Hepatitis among Substance Users (Réseau international sur l’hépatite chez les consommateurs de drogues). Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection. Int J Drug Policy. 2015 Nov 28. pii:S0955-3959(15)00351-5. doi: 10.1016/j.drugpo.2015.11.009. [Epub ahead of print] PMID: 26847504

Mahowald MK, Larney S, Zaller ND, Scharff N, Taylor LE, Beckwith CG, Noska A, Rich JD, Flanigan TP. Characterizing the Burden of Hepatitis C Infection Among Entrants to Pennsylvania State Prisons, 2004-2012. J Correct Health Care. 2016 Jan;22(1): 41-5. doi: 10.1177/1078345815618384. PMID: 26672118

Grebely J, Dore GJ, Greenwald R, Swan T, Barua S, Taylor LE. Hepatitis C Virus Treatment and Persons Who Inject Drugs. Ann Intern Med. 2016 Feb 2;164(3):203. doi: 10.7326/L15-0485. PMID: 26829914

Soipe AI, Razavi H, Razavi-Shearer D, Galárraga O, Taylor LE, Marshall BDL. Chronic hepatitis C virus (HCV) burden in Rhode Island: Modeling treatment scale-up and elimination. Epidemiol Infect. 2016 Aug 5:1-11. [Epub ahead of print]. PMID:27492142

Marshall AD, Saeed S, Barrett L, Cooper CL, Treloar C, Bruneau J, Feld JJ, Gallagher L, Klein MB, Krajden M, Shoukry NH, Taylor LE, Grebely J; Canadian Network on Hepatitis C (CanHepC). Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study. CMAJ Open. 2016 Oct 14;4(4):E605-E614. doi:10.9778/cmajo.20160008. PMID: 28018873

Taliano R, Godfrey M, Garland JM, Taylor LE, Cu-Uvin S, Resnick MB. The Great Mimicker Strikes Again: An Unusual Case of Syphilitic Hepatitis with Marked Sinusoidal Histiocytic Infiltrate. AJSP: Reviews and Reports.  2017 May/June 22(3):143–5.

Blackard JT, Ma G, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Sobel JD, Jamieson DJ, King CC. Cytokine/chemokine expression associated with Human Pegivirus (HPgV) infection in women with HIV. J Med Virolol.  2017 Apr 29 doi: 10.1002/jmv.24836. (Epub ahead of print] PMID: 28460153

Soipe AI, Taylor LE, Abioye AI, Green TC, Hadland SE, Marshall BDL. Prevalence of Hepatitis C Screening, Testing, and Care Experience Among Young Adults Who Use Prescription Opioids Nonmedically. J. Adolesc Health 2018 Jan;62(1):114-117. PMID: 29102250 PMCID: PMC5742053

Blackard JT, Ma G, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Sobel JD, Jamieson DJ, King CC. Cytokine/chemokine expression associated with Human Pegivirus (HPgV) infection in women with HIV. J Med Virol. 2017 Nov;89(11):1904-1911. doi: 10.1002/jmv.24836. Epub 2017 Aug 28.

Litwin AH, Jost J, Wagner K, Heo M, Karasz A, Feinberg J, Kim AY, Lum PJ, Mehta SH, Taylor LE, Tsui JI, Pericot-Valverde I, Page K; HERO Study Group. Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO Study. Contemp Clin Trials. 2019 Dec;87:105859. PMID: 31669450

Mercurio L, Taylor LE, Jarman AF. Neurosyphilis: Old Disease, New Implications for Emergency Physicians. Clin Pract Cases Emerg Med. 2019;4(1):46–50. PMID: 32064424 PCMCID: PMC701237

Farmakiotis D, Weiss Z, Brotherton AL, Morrissey PE, Gohh RY, Vieira K, Taylor LE, Garland J. Successful Kidney Transplantation in a Recipient Coinfected with Hepatitis C Genotype 2 and HIV from a Donor Infected with Hepatitis C Genotype 1 in the Direct-Acting Antiviral Era. Case Reports Hepatol. 2020;2020:7679147. PMCID: PMC7011348 PMID: 32082657

Wen X, Kogut S, Aroke H, Taylor L, Matteson K. Chronic opioid use in women following hysterectomy: Patterns and predictors. Pharmacoepidemiol Drug Saf. 2020 April;29(4):493-503. PMID: 32102109

Taylor LE. The Second Biggest Infectious Disease Killer in the U.S.: Hepatitis C Virus Infection and Steps Towards its Elimination in Rhode Island and Beyond. RI Med J (2013). 2020 Jun 1;103(5);19-21. PMID: 32481774

Barua S, Sprecht-Walsh S, Weiss Z, Butera J, Almhanna K, Hart S, Rodriguez J, Taylor LE. Intrahepatic Cholangiocarcinoma in a Patient with Hepatitis C: A Cautionary Tale. RI Med J (2013). 2020 Jun 1;103(5):30-34. PMID: 32481777

Taylor LE. Co-Localization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics. Clin Liver Dis. 2020 July;16(1);12-15.

Ngwaga T, Kong L, Lin D, Schoborg C, Taylor LE, Mayer KE, Klein RS, Celentano DD, Sobel JD, Jamieson DJ, King CC, Tavis JE, Blackard JT. Diversity of the hepatitis C virus NS5B gene during HIV co-infection. PLoS One. 2020 Aug 4; 15(8):e0237162. PMID: 32750098 PMCID: PMC7402467

Habchi J, Thomas AM, Sprecht-Walsh S, Arias E, Bratberg J, Hurley L, Hart S, Taylor LE. Optimizing Hepatitis C Virus (HCV) Treatment in a US Co-Located HCV/Opioid Agonist Therapy Program. Open Forum Infect Dis. 2020 Oct 13; 7(10): ofaa310. PMID: 33072802; PMCID: PMC7550646

Stein MD, Herman DS, Kim HN, Howell A, Lambert A, Madden S, Moitra E, Blevins CE, Anderson BJ, Taylor LE. Pinkston MM. A Randomized Trial Comparing Brief Advice and Motivational Interviewing for Persons with HIV-HCV Co-Infection Who Drink Alcohol. AIDS Behav. 2020 Oct 12. PMID: 33047258

Taylor LE. Losing Our Way: Caring for Patients Who May, Too Soon, Become Organ Donors. R I Med J (2013). 2021 Mar 1;104(2):10-12. PMID: 33648310

Taylor LE. One Small Step for Rhode Island Medicaid, One Giant Leap Towards Hepatitis C Elimination. R I Med J (2013). 2021 Dec 1;104(10):48-52. PMID: 34846383

Karasz A, Singh R, McKee MD, Merchant K, Kim AY, Page K, Pericot-Valverde I, Stein ES, Taylor LE, Wagner K, Litwin AH. Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs. J Subst Abuse Treat. 2022 Mar 18:108768. doi: 10.1016/j.jsat.2022.108768. Epub ahead of print. PMID: 35729038.

Webb AJ, Borrelli EP, Vyas A, Taylor LE, Buchanan AL. The effect of antiretroviral therapy with high central nervous system penetration on HIV-related cognitive impairment: a systematic review and meta-analysis. AIDS Care. 2022 Jul 18:1-12. doi: 10.1080/09540121.2022.2098231. Epub ahead of print. PMID: 35850626.

Litwin AH, Lum PL, Taylor LE, et al; HERO Study Group. Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial. Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1112-1127. PMID: 36370741.

Karasz A, Merchant K, Singh R, Thomas A, Borsuk C, McKee D, Duryea P, Kim AY, Mehta S, Norton BL, Page K, Pericot-Valverde I, Sedillo S, Stein ES, Taylor LE, Tsui J, Litwin A. The experience of re-infection among people who inject drugs successfully treated for hepatitis C. J Subst Use Addict Treat. 2023 Mar;146:208937. PMID: 36880897.

Tsui JI, Lum PL, Taylor LE, Mehta SH, Feinberg J, Kim AY, Norton BL, Niu J, Heo M, Arnsten J, Pericot-Valverde I, Thomas A, Blalock KL, Radick S, Murray-Krezan C, Page K, Litwin AH; HERO Study Group. Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs. Drug Alcohol Depend. 2023 Jun 17;247:109878. PMID: 37150144.

Karasz A, Merchant K, Arnsten J, Feinberg J, Kim AY, Lum PL, McKee MD, Mehta SH, Meissner P, Norton BL, Page K, Pericot-Valverde I, Singh R, Stein E, Taylor LE, Tsui JI, Wagner K, Litwin A. A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among PWID Infected with HCV: Qualitative Study of Stakeholder Perceptions and Experiences. J Med Internet Res. 2023 Jun 2;25:e38176. PMID: 37266986.

Pericot-Valverde I, Lopes SS, Nahvi S, Thrasher JF, Karasz A, Taylor LE, Mehta SH, Lum PJ, Tsui JI, Page K, Feinberg J, Kim AY, Norton BL, Arnsten JH, Fernandez-Artamendi S, Heo M, Litwin A; HERO Research Group. Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study. Open Forum Infect Dis. 2023 Oct 5;10(11):ofad498. PMID: 38023556; PMCID: PMC10644781.

Batchelder AW, Heo M, Foley JD, Sullivan MC, Lum P, Pericot Valverde I, Taylor LE, Mehta SH, Kim AY, Norton B, Tsui JI, Feinberg J, Page K, Litwin AH; HERO Study Group. Shame and stigma in association with the HCV cascade to cure among people who inject drugs. Drug Alcohol Depend. 2023 Dec 1;253:111013. PMID: 37951006.

Lopes SS, Pericot-Valverde I, Arnsten J, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Moschella P, Heo M, Litwin AH. Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study. Int J Drug Policy. 2023 Dec 15;123:104288. PMID: 38103458.

Uebelacker LA, Braun TD, Taylor LE, Saper R, Baldwin, Abrantes A, Tremont G, Toribio A, Kirshy S, Koch R, Lorin L, Van Noppen D, Anderson B, Roseen EJ, Stein MD. Evaluation of intervention components to maximize yoga practice among people with chronic pain taking opioid agonist therapy: A factorial experiment using the multiphase optimization strategy framework. Contemp Clin Trials. 2023 Dec 14:107411. PMID: 38103784.

Heo M, Norton BL, Pericot-Valverde I, Mehta SH, Tsui JI, Taylor LE, Lum PJ, Feinberg J, Kim AY, Arnsten J, Sprecht-Walsh S, Page K, Litwin AH; HERO Study Group; National Stakeholder Advisory Board. Optimal Hepatitis C Treatment Adherence Patterns and Sustained Virologic Response among People Who Inject Drugs: The HERO study. J Hepatol. Bottom of Form2024 Jan 17:S0168-8278(23)05374-6. PMID: 38242324

Epstein RL, Buzzee B, White LF, Feld JJ, Castera L, Sterling RK, Linas BP, Taylor LE. Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C Virus. J Viral Hepat. 2024 Feb 7. doi: 10.1111/jvh.13925. Online ahead of print. PMID: 38326950

Other Peer-Reviewed Publications

Feller E, Taylor LE. Ten things you may not know about hepatitis C infection. Med Health RI. 2002 Jun;85(6):180-1. PMID: 12101881

Berzin T, Allen S, Taylor L, Rich J, Feller E. Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections.  Med Health RI. 2002 Nov;85(11):341-4. PMID: 12462866

Mitty JA, Macalino G, Taylor L, Harwell JI, Flanigan TP. Directly observed therapy (DOT) for individuals with HIV: successes and challenges. MedGenMed. 2003 Feb 4;5(1):30. PMID 12827091

Taylor LE, Schwartzapfel B, Allen S, Jacobs G, Mitty J. Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence. Clin Infect Dis. 2003 Jun 1;36(11):1501-02. PMID: 12766851

Myung P, Mallette C, Taylor L, Allen S, Feller E. Sexual transmission of hepatitis C: practical recommendations.  Med Health RI. 2003 Jun;86(6):168-71. PMID: 12973887

Rich JD, Taylor LE, Allen SA. Screening for hepatitis C virus infection in adults.  Ann Intern Med. 2004 Oct 5;141(7):575- PMID: 15466778

Allen SA, Spaulding AC, Taylor LE, Rich JD. Confined treatment continued. 2004 Mar;126(3):928. PMID: 14988852

Taylor LE, Rich JD, Tashima KT. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients. N Engl J Med. 2004 Nov 25;351(22): 2340-2. PMID: 15564553

Grebely J, Oser M, Taylor LE, Dore GJ. Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels. J Infect Dis 2013 Mar;207 Suppl 1:S19–25. doi: 10.1093/infdis/jis928. PMID: 23390301 PMCID: PMC3565594

Taylor LE and Fierer DS. Treatment of Early Hepatitis C Infection in HIV-infected Men –When to Treat, Whom, and with What? Curr Treat Options Infect Dis (2016) 8:426-437. DOI 10.1007/s40506-016-0093-5.

Spaulding AC, Graham CS, Akiyama MJ, Chhatwal J, Nijhawan AE, Ninburg MH Rich JD, Strick LB, Taylor LE, Trooskin SB, Westergaard RP, Sabol WJ. Letter to the Editor: Hepatitis C Virus Prevalence Estimates Among Incarcerated Persons. Hepatology. 2019 Aug;70(2):758-759. PMID: 30938455 PMCID: PMC7644139.

Book and Book Chapters

Limiting Harm from Chronic Hepatitis C Infection for HIV-Positive People with Drug Dependency: Prevention and Treatment. Taylor LE, Schwartzapfel B, Gholam PM. In Delivering HIV Care and Treatment for People Who Use Drugs: Lessons from Research and Practice. Open Society Institute, New York, NY, July 2006: 95-109. initiatives/health/focus/ihrd/articles_publications/publications/delivering_20060801


Postgraduate Honors and Awards

2000 - Brown University School of Medicine MD Class of 2000 Resident Teaching Award “…for an unwavering respect for all the people – patients and young physicians all under your care…”

2003 - Collaborative Leadership in Action Award for HIV/Hepatitis C Virus (HCV) Coinfection, Rhode Island NonProfit Resources

2008 - 2008 Red Ribbon Community Service Award
Dr. Alvan Fisher Medical Service Award for help, support and commitment to HIV/AIDS work and AIDS Project Rhode Island

2010 - Clinical Infectious Diseases Award for Outstanding Review

2011 - Fellow, American College of Physicians

2014 - Rhode Island Medical Women’s Association (RIMWA)
2014 Woman of the Year

2014 - The RI Department of Health Office of HIV/AIDS & Viral Hepatitis Excellence in Medicine Award for hard work and dedication to the public health of the citizens of the
State of RI, advocacy for patients, and leadership in advancing best practices that help identify more new HCV patients in RI and link them to care.

2014 - Rhode Island Monthly’s 2014 Most Powerful Women in Rhode Island. One of 30 Women Selected.

2016 - Viral Hepatitis Testing Recognition Award from the Acting Assistant Secretary for Health, Karen B. DeSalvo, MD, MPH, MSc. Presented during the National Hepatitis
Testing Day Observance, Responding to Viral Hepatitis in the United States, The White House, Washington, DC. May 19, 2016

2016 - Fellow, American Association for the Study of Liver Disease

2017 - Rhode Island Monthly’s Top Doc. Rhode Island Physicians Name the Best 150 in the State

2017 - Economist Intelligence Unit Path to Zero Program, 2017 HCV Change Maker. HCV Change Makers recognition program celebrates the creative efforts of 18 individuals or
organizations who have contributed significantly to eliminating HCV. The program aims to inspire and guide others on the path to HCV elimination, and to spark debate
and action on HCV policy, access to care and equity.

2017 - NOhep Visionary. Led by a working group comprised of the World Hepatitis Alliance, WHO, Coalition for Eradication of Viral Hepatitis in Asia Pacific, European Liver Patients Association and CDC, NOhep builds global awareness and supports the WHO’s Elimination Strategy.

2019- Rhode Island Pharmacists Association Charles Hachadorian Jr. Award for Dr. Taylor’s recognition of the contribution the profession of pharmacy has made to healthcare and active and dedicated support of these efforts.

2020- American Medical Association Women Physicians Section 2020 Inspiration Award Honoree

2021- Fellow, Infectious Diseases Society of America (IDSA)